Quick Enquire
Ivacaftor intermediates manufacturers

Ivacaftor intermediates manufacturers

A.R. Life Sciences are top-class Ivacaftor intermediates manufacturers. Ivacaftor intermediates are used to treat cystic fibrosis caused due to certain mutations. It can be used for patients only with specific gene mutations related to cystic fibrosis. We follow GMP and ICH standards to develop superior quality products. We have standard operating procedures for acquiring raw material, production, and final dispatch of goods. We go through a series of checks to ensure great quality. Our organization is ISO 9001:2015 certified, with our units being GMP certified, and one of our units is approved by USFDA.
With all contemporary and sophisticated equipment, our manufacturing units are furnished with everything that is necessary to produce superior grade products. Further, our laboratory is fully equipped for the formulation of good quality drugs. As Ivacaftor intermediates manufacturers we have modern testing units that ensure accuracy in chemical composition, long usage of our pharmaceutical products.

Ivacaftor is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator gene, who account for 4–5% cases of cystic fibrosis.




  • Product Features
  • Advantages
  • Applications
  • Specifications
  • Form: Powder
  • Minimum order quantity: 100gram
  • Categories: Pharma intermediates, Pharma API, Pharmaceutical intermediates, Pharmaceutical API, Active Pharmaceutical Ingredients
  • Usage/Application: Commercial
  • Manufacturer: A. R. Life sciences Pvt Ltd.
  • Cancer (Bendamustine intermediates, Imatinib intermediates)
  • Cardiovascular (Clopidogrel bisulphate intermediate & API)
  • Anti-Coagulant (Dabigatran intermediates & API, CamostatMesylate intermediates & API)
  • Leukemia (Dasatinib intermediates)
  • Pain (Elagolix intermediate)
  • Gaucher disease (Eliglustat intermediates)
  • Osteoporosis (Ibandronate intermediate)
  • Cystic fibrosis (Ivacaftor intermediates)
  • Hyperuricemia (Lesinurad intermediate)
  • Urinary Incontinence (Mirabegron, Solifenacin intermediates)
  • Nausea & vomiting (Ondansetron intermediates)
  • Anti-Psychotic (Paliperidone/Risperidone, Quetiapine intermediates)
  • Acute Diarrhoea (Racecadotril intermediates)
  • Deep vein thrombosis (Rivaroxaban intermediate)
  • Type 2 Diabetes (Sitagliptin intermediates)
  • NSAID (Etodolac API)
  • Antibiotic (Sparfloxacin API)
  • Anti-Arrhythmic agent (Adenosine API)
  • Anti-Lipemic (Rosuvastatin calcium API)
  • Iron chelator (Deferasirox)
  • Purity, Grade

Ivacaftor Intermediates Specifications:

Intermediate CAS No API/End Use Status Purity
Ethyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate 52980-28-6 Ivacaftor Commercial 100%
4-oxo-1,4-dihydroquinoline-3-carboxylic acid 13721-01-2 Ivacaftor Commercial 98.26%
5-Amino-2,4-ditert-butylphenol 873055-58-4 Ivacaftor Lab Scale